Thromboprophylaxis in Patients Undergoing Orthopedic Surgeries; Comparison Between Rivaroxaban and Enoxaparin
Status:
Unknown status
Trial end date:
2018-03-30
Target enrollment:
Participant gender:
Summary
The main objective is to reduce the incidence of venous thromboembolism (VTE) in orthopedic
postoperative patients based on the potential benefit of using rivaroxaban as a monotherapy.
It is around efficacy and safety evaluation of using rivaroxaban as a monotherapy
prophylactic agent in patients undergoing orthopedic surgeries taking into the account the
reliable selection of patients most benefit.
Answering questions about additional cost benefit from the perceptive of the cost-effective
analysis on extrapolating the results emerged to our university teaching hospital setting are
going to be evaluating as well.
Phase:
Phase 3
Details
Lead Sponsor:
Ahmed AbdelMoneim Hassan Ali
Collaborators:
Beni Suef school of pharmacy Beni Suef University Teaching Hospital Beni-Suef University